Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
Santa Rosa, Solano/Vallejo, San Francisco, Greater Sacramento Valley, San Mateo, East Bay, Modesto, Palo Alto/Santa Cruz
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
NRG-GU011: A Phase II Double-Blinded, Placebo-Controlled Trial of PROstate OligoMETastatic RadiotHErapy With or Without ANdrogen Deprivation Therapy in Oligometastatic Prostate Cancer (NRG Promethean)